P. Trifillis

发表

Identification of Target Messenger RNA Substrates for the Murine Deleted in Azoospermia-Like RNA-Binding Protein1

Xinfu Jiao, M. Kiledjian, P. Trifillis, 2002, Biology of reproduction.

Expression Studies of δ-Globin Gene Alleles Associated with Reduced Hemoglobin A2 Levels in Greek Cypriots*

S. Surrey, K. Adachi, P. Trifillis, 1996, The Journal of Biological Chemistry.

Identification of four novel delta-globin gene mutations in Greek Cypriots using polymerase chain reaction and automated fluorescence-based DNA sequence analysis.

S. Surrey, P. Ioannou, P. Trifillis, 1991, Blood.

Polymerization of Three Hemoglobin A2 Variants Containing Valδ6 and Inhibition of Hemoglobin S Polymerization by Hemoglobin A2*

S. Surrey, K. Adachi, P. Trifillis, 1996, The Journal of Biological Chemistry.

Different hematological phenotypes caused by the interaction of triplicated α‐globin genes and heterozygous β‐thalassemia

P. Fortina, S. Surrey, C. Camaschella, 1997 .

Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay.

S. Peltz, F. He, A. Jacobson, 2000, RNA.

Purification and RNA Binding Properties of the Polycytidylate-Binding Proteins αCP1 and αCP2

M. Kiledjian, P. Trifillis, N. Day, 1999 .

Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia.

P. Fortina, S. Surrey, C. Camaschella, 1997, American journal of hematology.

Simian virus 40 T antigen can transcriptionally activate and mediate viral DNA replication in cells which lack the retinoblastoma susceptibility gene product

J. Alwine, P. Trifillis, J. Picardi, 1990, Journal of virology.

Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy

N. Goemans, C. McDonald, J. Signorovitch, 2022, Journal of neuromuscular diseases.

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients

F. Muntoni, R. Able, A. Kristensen, 2021, Journal of comparative effectiveness research.

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry.

E. Mercuri, F. Muntoni, I. Desguerre, 2019, Journal of comparative effectiveness research.

Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives

Satrajit Roychoudhury, J. Barrett, Jing Liu, 2022, Journal of clinical pharmacology.

Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform

Jean Hedrick, S. Peltz, T. Davis, 2016, PloS one.

PTC124 targets genetic disorders caused by nonsense mutations

Meenal Patel, Feng He, Masataka Kawana, 2007, Nature.

Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease.

S. Surrey, S. Ballas, R. Wood, 1990, The Journal of clinical investigation.

Analysis of delta-globin gene mutations in Greek cypriots.

S. Surrey, P. Ioannou, P. Trifillis, 1993, Blood.

SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

Anirvan Ghosh, Roland Schmucki, Hasane Ratni, 2014, Science.

Evaluating longitudinal therapy effects via the North Star Ambulatory Assessment

Lee-Jen Wei, F. Muntoni, K. Flanigan, 2021, Muscle & nerve.

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial

S. Peltz, P. Shieh, C. McDonald, 2018, Muscle & nerve.

Longitudinal Evaluation of Working Memory in Duchenne Muscular Dystrophy

G. Elfring, P. Trifillis, M. Thangarajh, 2020, Journal of clinical medicine.

Finding the right RNA: identification of cellular mRNA substrates for RNA-binding proteins.

M. Kiledjian, P. Trifillis, P Trifillis, 1999, RNA.

An mRNA Stability Complex Functions with Poly(A)-Binding Protein To Stabilize mRNA In Vitro

M. Kiledjian, Zuo-ren Wang, P. Trifillis, 1999, Molecular and Cellular Biology.

Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study

E. Mercuri, F. Muntoni, I. Desguerre, 2020, Journal of comparative effectiveness research.

Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy.

Lee-Jen Wei, G. Comi, R. Finkel, 2020, Journal of comparative effectiveness research.

Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status

P. Shieh, C. McDonald, J. Signorovitch, 2023, Journal of comparative effectiveness research.

Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis

F. Muntoni, I. Desguerre, A. Kristensen, 2023, Journal of Neurology.

Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.

S. Peltz, S. Apkon, C. Campbell, 2021, Journal of comparative effectiveness research.

The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy

S. Peltz, G. Elfring, P. Trifillis, 2018, Neurology.